OpenVSafe by OpenVAERS
Search V-safe

757-23942-48523

2 vaccinations 5 coded responses 20 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
750 / TX
Registered
2021-04-09
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-07
    Dose 1 — Moderna
  2. 2021-04-09
    Registered in v-safe
  3. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  4. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains, Muscle or body aches
    Adult check-in
  6. 2021-04-14
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-04-30
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-05-05
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-05-12
    Health check-in — day 35, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-20
    Dose 2 — Moderna
  12. 2021-05-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Sensitive skin — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: extreme skin sensitivity all over
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Sensitive skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: moderate hypersensitivity all over skin
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Menstruation irregular — Feeling: Fair · Headache
    Free text: irregular period, not typical
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  16. 2021-05-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-06-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-06-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-06-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-08-21
    Survey response — 3 months, dose 2
    MedDRA: Body temperature increased, Chest discomfort, Dizziness, Dyspnoea, Productive cough, Respiratory tract congestion, SARS-CoV-2 test positive, Sputum discoloured — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tested positive for covid. Shortness of breath/lightheadedness with a lot of talking, pressure within chest, congestion & green mucus, persistent green & clear phlegm-producing cough. Yesterday evening started 100.0F fever, no fever today (~½ day)
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  23. 2021-08-21
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-08-26
    Call successful
    Not applicable - Accidental Reporting
  25. 2022-05-23
    Survey response — 12 months, dose 2
    MedDRA: Chills, Condition aggravated, Hyperhidrosis, Menstruation irregular, Night sweats, Pre-existing disease, Raynaud's phenomenon — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Irregular menstrual bleeding/spotting Moderate night sweats (no prior history) Increased perspiration during day, even when NOT hot/a bit chilled Worsened symptoms from Reynauds & poor circulation
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-05-23
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  27. 2022-05-24

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Moderna
22021-05-20Moderna

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 2

2021-05-21

Systemic reaction (other): extreme skin sensitivity all over

2021-05-22

Systemic reaction (other): moderate hypersensitivity all over skin

2021-05-23

Systemic reaction (other): irregular period, not typical

Release 9 — 3 months, dose 2

2021-08-21

Symptoms: Tested positive for covid. Shortness of breath/lightheadedness with a lot of talking, pressure within chest, congestion & green mucus, persistent green & clear phlegm-producing cough. Yesterday evening started 100.0F fever, no fever today (~½ day) cut off by CDC

Release 11 — 12 months, dose 2

2022-05-23

Symptoms: Irregular menstrual bleeding/spotting Moderate night sweats (no prior history) Increased perspiration during day, even when NOT hot/a bit chilled Worsened symptoms from Reynauds & poor circulation

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBody temperature increased ✓ · ✓
SDChest discomfort ✓ · ✓
SDChills · · ✓
SDCondition aggravated · · ✓
SDDizziness ✓ · ✓
SDDyspnoea ✓ · ✓
SDHyperhidrosis · · ✓
SDMenstruation irregular · · ✓
SDNight sweats · · ✓
SDPre-existing disease · · ✓
SDProductive cough ✓ · ✓
SDRaynaud's phenomenon · · ✓
SDRespiratory tract congestion ✓ · ✓
SDSARS-CoV-2 test positive ✓ · ✓
SDSputum discoloured ✓ · ✓
SROMenstruation irregular ✓ ✓ ✓
SROSensitive skin ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release